homocysteine and Thromboembolism, Venous

homocysteine has been researched along with Thromboembolism, Venous in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (26.09)	29.6817
2010's	12 (52.17)	24.3611
2020's	5 (21.74)	2.80

Authors

Authors	Studies
Chen, X; Jia, R; Li, G; Li, Z; Wang, Y	1
Braekkan, SK; Hansen, JB; Morelli, VM; Tøndel, BG	1
Głowacki, R; Klajmon, A; Kopiński, P; Natorska, J; Piechocka, J; Ząbczyk, M	1
Aday, AW; Christen, WG; Duran, EK; Kim, E; Manson, JE; Pradhan, AD; Ridker, PM; Van Denburgh, M	1
Ames, PRJ; Caruso, M; D'Andrea, G; Gentile, F; Iannaccone, L; Margaglione, M; Marottoli, V	1
Armstrong, EM; Bellone, JM; Hornsby, LB; Phillippe, HM; Treadway, S	1
Whayne, TF	1
Borowczyk, K; Głowacki, R; Mielimonka, A; Stachniuk, J; Szlauer, A; Undas, A	1
Freiberg, RA; Glueck, CJ; Jetty, V; Wang, P	1
Ray, JG	1
Barro, C; Bosson, JL; Carpentier, P; Desruet, MD; Ducros, V; Pernod, G; Polack, B; Yver, J	1
Hanta, I; Hasturk, S; Karatasli, M; Koseoglu, Z; Satar, S; Soydas, Y	1
Adam, DJ; Bradbury, AW; Darvall, KA; Fegan, CD; Sam, RC; Silverman, SH	1
Aksungar, FB; Celik, A; Coksuer, H; Haliloglu, B; Ilter, E; Ozekici, U	1
Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A	1
Chen, K; Jin, X; Yan, L; Yin, G; Zhang, Z	1
Ehnholm, C; Herrmann, M; Keech, AC; Sullivan, DR; Veillard, AS; Whiting, MJ	1
Bern, M; McCarthy, N	1
Abudureheman, K; Hu, XM; Mahemuti, A; Xia, YN	1
Folsom, AR	1
Abaci, N; Arseven, O; Diz-Kucukkaya, R; Issever, H; Kiyan, E; Okumus, G; Tabak, L; Unaltuna, NE; Unlucerci, Y	1
Burcombe, RJ; Cladd, H; Cooper, P; Gatt, A; Makris, A; Makris, M; Smith, JM; Thompson, D	1
Abalain, JH; Lacut, K; Le Gal, G; Mottier, D; Oger, E	1

Reviews

4 review(s) available for homocysteine and Thromboembolism, Venous

Article	Year
Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review. Journal of thrombosis and haemostasis : JTH, 2022, Volume: 20, Issue:10 Topics: Anticoagulants; Biomarkers; C-Reactive Protein; Homocysteine; Humans; Ischemic Stroke; Pulmonary Embolism; Risk Factors; Stroke; Venous Thromboembolism	2022
Inherited Thrombophilia. Journal of pharmacy practice, 2014, Volume: 27, Issue:3 Topics: Hemostasis; Homocysteine; Humans; Mutation; Thrombophilia; Thrombosis; Venous Thromboembolism; Vitamin B Complex	2014
Methylenetetrahydrofolate reductase C677T polymorphism, venous thrombosis, cardiovascular risk, and other effects. Angiology, 2015, Volume: 66, Issue:5 Topics: Animals; Biomarkers; Comorbidity; Dietary Supplements; Gene Frequency; Genetic Predisposition to Disease; Health Status; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Genetic; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thromboembolism; Vitamin B Complex	2015
Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism. Current opinion in pulmonary medicine, 2008, Volume: 14, Issue:5 Topics: Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Polymorphism, Genetic; Risk Factors; Venous Thromboembolism	2008

Trials

1 trial(s) available for homocysteine and Thromboembolism, Venous

Article	Year
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clinical chemistry and laboratory medicine, 2012, Volume: 50, Issue:12 Topics: Biomarkers; Double-Blind Method; Female; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Male; Placebos; Proportional Hazards Models; Venous Thromboembolism	2012

Other Studies

18 other study(ies) available for homocysteine and Thromboembolism, Venous

Article	Year
The potential of folic acid and homocysteine as novel serum markers for venous thromboembolism in cancer patients. Clinical hemorheology and microcirculation, 2022, Volume: 82, Issue:1 Topics: Biomarkers; Factor VIII; Folic Acid; Homocysteine; Humans; Neoplasms; Tissue Plasminogen Activator; Venous Thromboembolism	2022
Plasma thiol levels and methylenetetrahydrofolate reductase gene c.665C > T and c.1286A > C variants affect fibrin clot properties in Polish venous thromboembolic patients. Molecular genetics and metabolism, 2023, Volume: 139, Issue:3 Topics: Fibrin; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Poland; Sulfhydryl Compounds; Thrombosis; Venous Thromboembolism	2023
Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women. Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:7 Topics: Adult; Age Factors; Biomarkers; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Middle Aged; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sex Factors; Time Factors; United States; Venous Thromboembolism	2021
Homozygous methylentetrahydrofolate reductase C667T genotype anticipates age at venous thromboembolism by one decade. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Sep-01, Volume: 32, Issue:6 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Blood Coagulation; Female; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Retrospective Studies; Venous Thromboembolism	2021
Protein N-linked homocysteine is associated with recurrence of venous thromboembolism. Thrombosis research, 2015, Volume: 136, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Male; Middle Aged; Venous Thromboembolism; Young Adult	2015
Venous Thromboembolism After Knee Arthroscopy in Undiagnosed Familial Thrombophilia. Orthopedics, 2016, Nov-01, Volume: 39, Issue:6 Topics: Antibodies, Anticardiolipin; Antithrombin III Deficiency; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Arthroscopy; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Factor V; Factor VIII; Factor XI; Female; Homocysteine; Humans; Knee Joint; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Venous Thromboembolism	2016
Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2009, Volume: 15, Issue:5 Topics: Adult; Aged; Biomarkers; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Prevalence; Prospective Studies; Risk Factors; Ultrasonography; Venous Thromboembolism; Young Adult	2009
Plasma homocysteine level and 677C-->T mutation on the MTHFR gene in patients with venous thromboembolism. Bratislavske lekarske listy, 2010, Volume: 111, Issue:2 Topics: Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Venous Thromboembolism	2010
The incidence of raised procoagulant factors and hyperhomocysteinaemia in Chinese patients with chronic venous insufficiency. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2010, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Asian People; Blood Coagulation Factors; Chronic Disease; Comorbidity; Factor IX; Factor VIII; Factor XI; Female; Homocysteine; Hong Kong; Humans; Hyperhomocysteinemia; Male; Middle Aged; United Kingdom; Venous Insufficiency; Venous Thromboembolism; White People	2010
Negative correlation between D-dimer and homocysteine levels during pregnancy and the postpartum period: a prospective study. European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 153, Issue:1 Topics: Adult; Dimerization; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Postpartum Period; Pregnancy; Prospective Studies; Venous Thromboembolism; Young Adult	2010
Altered fibrin clot properties in patients with retinal vein occlusion. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:12 Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis	2011
C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: a population-based case-control study. Molecular medicine reports, 2012, Volume: 6, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Venous Thromboembolism	2012
Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1 Topics: Activated Protein C Resistance; Antibodies, Anticardiolipin; Antithrombin III; Biomarkers; Blood Coagulation Factors; Diagnostic Tests, Routine; Factor V; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Preoperative Care; Protein C; Recurrence; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism	2013
[Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism]. Zhonghua xin xue guan bing za zhi, 2012, Volume: 40, Issue:12 Topics: Adult; Aged; Asian People; Ethnicity; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Single Nucleotide; Risk Factors; Venous Thromboembolism	2012
Homocysteine and venous thromboembolism in LITE. American journal of hematology, 2007, Volume: 82, Issue:11 Topics: Biomarkers; Case-Control Studies; Cohort Studies; Homocysteine; Humans; Longitudinal Studies; Odds Ratio; Reproducibility of Results; Venous Thromboembolism	2007
Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2008, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Factor V; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Mutation; Protein C; Prothrombin; Risk Factors; Thrombophilia; Venous Thromboembolism	2008
Hyperhomocysteinemia in women with advanced breast cancer. International journal of laboratory hematology, 2007, Volume: 29, Issue:6 Topics: Breast Neoplasms; Cohort Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Neoplasm Metastasis; Neoplasm Staging; Venous Thromboembolism	2007
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia? Thrombosis research, 2008, Volume: 122, Issue:3 Topics: Aged; Aged, 80 and over; Case-Control Studies; Clofibric Acid; Databases, Factual; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Hypolipidemic Agents; Male; Middle Aged; Risk Factors; Surveys and Questionnaires; Venous Thromboembolism	2008